Only men with a dangerous genetic variant and a family history of cancer should be offered screening, say UK advisors.
Prostate cancer kills more than 10,000 men in England each year. For decades, urologists across the country have been ...
RICHMOND, Va. (January 20, 2026) – Researchers at VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) were recently awarded a $1.8 million, 3-year grant from the ...
Two enzymes from the protein disulphide isomerase (PDI) family enable prostate cancer cells to grow, survive, and resist treatment. This discovery, however, could be taken as an advantage to improve ...
A proof-of-concept study has created a blueprint for producing prostate cancer treatment more efficiently. Researchers at the ...
NHS advisors have again rejected pleas for potentially life-saving routine prostate cancer screening after concluding that ...
Doctors have long looked to the hormone testosterone as a piece of the prostate cancer puzzle. The man on the other end was J. Bruce Hunsicker, an Akron-based lawyer with prostate cancer who had ...
New findings highlight Telomir-1’s impact on CASP8 and GSTP1, two critical genes that regulate cell death and glutathione-based detoxification pathways often disrupted in cancer. MIAMI, FLORIDA / ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results